AEX 19
Alternative Names: AEX-19Latest Information Update: 22 Mar 2024
At a glance
- Originator Aexon Labs
- Class Sleep disorder therapies; Small molecules
- Mechanism of Action Orexin receptor type 1 agonists; Orexin receptor type 2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Idiopathic hypersomnia; Narcolepsy; Neurodegenerative disorders